Cargando…
A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence
Doxorubicin, an anthracycline antibiotic, is a commonly used anticancer drug. In spite of its widespread usage, its therapeutic effect is limited by its cardiotoxicity. On the cellular level, Doxorubicin-induced cardiotoxicity manifests as stress induced premature senescence. Previously, we demonstr...
Autores principales: | Ghosh, Asish K., Rai, Rahul, Park, Kitae E., Eren, Mesut, Miyata, Toshio, Wilsbacher, Lisa D., Vaughan, Douglas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341920/ https://www.ncbi.nlm.nih.gov/pubmed/27736799 http://dx.doi.org/10.18632/oncotarget.12494 |
Ejemplares similares
-
Epigenetic clock analyses of cellular senescence and ageing
por: Lowe, Donna, et al.
Publicado: (2016) -
BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21
por: Lee, Hyemin, et al.
Publicado: (2016) -
DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging
por: Olivieri, Fabiola, et al.
Publicado: (2015) -
Identification of the lncRNA, AK156230, as a novel regulator of cellular senescence in mouse embryonic fibroblasts
por: Chen, Yu-ning, et al.
Publicado: (2016) -
Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)